Literature DB >> 10517034

Glycopyrrolate: a useful drug in the palliation of mechanical bowel obstruction.

M P Davis, A Furste.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10517034     DOI: 10.1016/s0885-3924(99)00063-9

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


× No keyword cloud information.
  7 in total

Review 1.  [Pharmacological treatment of malignant bowel obstruction in severely ill and dying patients : a systematic literature review].

Authors:  C Klein; S Stiel; J Bükki; C Ostgathe
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

Review 2.  Treatment of non-pain-related symptoms.

Authors:  Charles F von Gunten; Ellin Gafford
Journal:  Cancer J       Date:  2013 Sep-Oct       Impact factor: 3.360

Review 3.  Modern management of cancer-related intestinal obstruction.

Authors:  M P Davis; C Nouneh
Journal:  Curr Oncol Rep       Date:  2000-07       Impact factor: 5.075

4.  Reducing gastric secretions--a role for histamine 2 antagonists or proton pump inhibitors in malignant bowel obstruction?

Authors:  K Clark; L Lam; D Currow
Journal:  Support Care Cancer       Date:  2009-03-17       Impact factor: 3.603

Review 5.  Recent advances in malignant bowel obstruction: an interface of old and new.

Authors:  Vinaya Potluri; Donna S Zhukovsky
Journal:  Curr Pain Headache Rep       Date:  2003-08

Review 6.  Modern management of cancer-related intestinal obstruction.

Authors:  M P Davis; C Nouneh
Journal:  Curr Pain Headache Rep       Date:  2001-06

7.  MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer.

Authors:  Ainhoa Madariaga; Jenny Lau; Arunangshu Ghoshal; Tomasz Dzierżanowski; Philip Larkin; Jacek Sobocki; Andrew Dickman; Kate Furness; Rouhi Fazelzad; Gregory B Crawford; Stephanie Lheureux
Journal:  Support Care Cancer       Date:  2022-03-10       Impact factor: 3.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.